Alumis Inc. (ALMS) Stock Grade

About Alumis Inc.'s fundamentals

Alumis Inc. is a biotechnology company with a market capitalization of $883.8 million that reported zero revenue growth year-over-year, indicating no expansion in sales. The company posted a significant net loss in its latest annual statement, resulting in a net margin of -1011.8%, which reflects substantial operating expenses relative to minimal or no revenue generation. The company does not pay a dividend and lacks meaningful profitability metrics, which is not uncommon for early-stage biotechnology firms that typically invest heavily in research and development before generating commercial revenue.